12
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 677-687 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • In vitro activation of human macrophages by alginate-polylysine microcapsules. PUEYO, M. E., DARQUY, S., CAPRON, F., and REACH, G., J. Biomater. Sci. Polym. Ed., 1993. 5, (3), 197–203.
  • Assessment of adsorption of liposomes on a phospholipid polymer surface using a quartz crystal microbalance system. TANAKA, S. IWASAKI, Y., ISHIHARA, K., and NAKABAYASHI, N., Macromol. Rapid Commun., 1994, 15, (4), 319–326.
  • Manufacture and in-vitro assessment of bromsulfthalein and phenolphthalein-loaded polyester microspheres. TIAN, Y., PARASRAMPURIA, D., KANKE, M., and HICKEY, A. J., Drug Dev. Ind. Pharm., 1994, 20, (7), 1159–1178.
  • Effect of plasticizer on microencapsulation with enteric polymer by surface neutralization method. TAKAHATA, H., and KOBAYASHI, M., Chem. Pharm. Bull., 1993, 41, (12), 2141–2146.
  • Improvement of encapsulation efficiency of timolol maleate in liposomes by the freeze-thaw- ing method. SAMMOUR, O.A., Zagazigj. Pharm. Sci., 1992, 1, (1-2), 34–41.
  • Pharmacokinetics of cyclophosphamide entrapped in polyphase liposomes. GUAN, S., WANG, D., ZHANG, J., and Gu, X., Shenyang Yaoxueyan Xuebao, 1993, 10, (3), 209–211.
  • Development and evaluation of sustained-release ibuprofen-wax microspheres. II: In vitro dissolution studies. ADEYEYE, C. M., and PRICE, J. C., Pharm. Res., 1994, 11, (4), 575–597.
  • Preparation of agglomerated crystals for direct tabletting and microencapsulation by the spherical crystallization technique with a continuous system. NIWA, T., TAKEUCHI, H., HINO, T., Frox, A., KAWASHIMA, Y., and KIUCHI, K., Pharm. Res., 1994, 11, (4), 478–484.
  • Pharmacokinetics and safety a of unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. LEE, J. W., AMANTEA, M. A., FRANCIS, P. A., NAVARRO, E. E., BACHER, J., Pizzo, P. A., and WALSH, T. J., Antimicrob. Agents Chemother, 1994, 38, (4), 713–718.
  • Calcein release from temperature-sensitive liposome with or without stirring. ONO, A., YAMAGUCHI, M., HORIKOSHI, I., SHINTANI, T., and UENO, M., Biol. Pharm. Bull., 1994, 17, (1), 166–168.
  • The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat. TEDER, H., and JOHANSSON, C. J., Anticancer Res., 1993, 13, (6A), 2161–2164.
  • Piroxicam release from spray-dried biodegradable microspheres. WAGENAAR, B. W., and MUELLER, B. W Biomaterials, 1994, 15, (1), 49–54.
  • Preparation and characterization of albumin-heparin microspheres. CREMERS, H. F. M., KWON, G., BAE,Kim, S. W., VERRIJK, R., NOTEBORN, H. P. J. M., and FEIJEN, J., Biomaterials,1994, 15, (1), 38–48.
  • Cryoprotective effect of gelatin and albumin on recombinant human tumor necrosis factor liposome. YASUI, K., FUJIOKA, H., and NAKAMURA, Y., Chem. Pharm. Bull., 1993, 41, (12), 2138–2140.
  • Multilamellar liposomes as a model for evaluating the percutaneous absorption enhancing activity of terpenes. KRAGH, K., TAKAYAMA, K., SATO, M., and NAGAI, T., STP Pharma. Sci., 1993, 3, (6), 499–506.
  • In vitro and in vivo evaluation of TRH release from copoly(DL-lactic/glycolic acid) microspheres. HEYA, T., OKADA, H., OGAWA, Y., and Toouciii, H., J. Pharm. Sci., 1994, 83, (5), 636–640.
  • Formulation and evaluation of polyacrylamide microcapsules containing 5-fluorouracil. SAWANT, K. K., and MURTHY, R. S. R., Indian. y. Pharm. Sci., 1993, 55, (6), 221–224.
  • Disposition of antigen-presenting liposomes in vivo: effect on presentation of herpes simplex virus antigen rgD. Ho. R. J. Y., BURKE, R. L., and MERIGAN, T. C., Vaccine, 1994, 12, (3), 235–242.
  • The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. ALLEN, T. M., Adv. Drug Delivery Rev., 1994, 13, (3), 285–309.
  • Biodistribution and therapeutic utility of liposomal drug carrier systems. STORM, G., VINGERHOEDS, M. H., HAISMA, H., BAKKER-WOUDENBERG, I. A. J. M., BLUME, G., CEVC, G., and CROMMELIN, D. J. A., J. Liposome Res., 1993, 3, (3), 551–562.
  • Targeting applications of biotinylated liposomes. SORIA, M. R., LOUGHREY, H., FERRARETTO, A., CANNON, A. M., ACERBIS, G., SUDATI, F., BOTTIROLI, G., and MASSERINI, M., J. Liposome Res., 1993, 3, (3), 543–549.
  • The dynamic structure of micelles and liposomes and their self-fluorescence in absence of dye. SHAHINIAN, A. A. and BAGDASARIAN, V. V., Mol. Cryst. Lig. Cryst. Sci. Technol. (Sect. A), 1994, 241, 55–68.
  • Preparation of Laurinol-PS microsphere and its release mechanism. CHEN, J., CHEN, Y., and Li, Y., Gongneng Gaofenzi Xuebao, 1992, 5, (3), 242–247.
  • Microencapsulation in the food industry. CHLENOK, V. A., Tr. Vses. Semin. pa Kolloid Khimii i Fiz-khim Mekh Pishch i Bioaktiv Dispers Sistem (1989–90) AN SSSR, 1991, 237–242.
  • Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides. HOEDEMAKERS, R. M. J., VOSSEBELD, P. J. M., DAEMEN, T., and SCHERPHOF, G. L.,.7. Immunother. Emphasis Tumor Immunol., 1993, 13, (4), 252–260.
  • Activation of Fc receptor-mediated phagocytosis by mouse peritoneal macrophages following the intraperitoneal administration of liposomes. ARAMAKI, Y., MURA I, M., and TSUCHIYA, S., Pharm. Res., 1994, 11, (4), 518–521.
  • Use of liposome-immunopotentiated exOpolysaccharide as a component of an ovine mastitis staphylococcal vaccine. AMORENA, B. BASELGA, R., and ALBIZU, I., Vaccine, 1994, 12, (3), 243–249.
  • Calcification of liposomes and red cell ghosts in vitro and in vivo. KIM, K. M., Cells Mater., 1993, 3, (3), 293–304.
  • Influence of liposome phospholipids on collagen-induced platelet aggregation. ZAKREVSKY, V. I., KUBATIEV, A. A., and GALAEV, Ye. V., Vopr. Med. Khim., 1993, 39, (5), 21–23.
  • Detergent-induced liposome loading (DILL). SCHUBERT, R., Proc. MoBBEL., 1991, 5, 73–82.
  • Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal. PRAKASH, S., and CHANG, T. M. S., Biomater., Artif. Cells, Immobilization Biotechnol., 1993, 21, (5), 629–636.
  • Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naph-thalocyanine. BIOLO, R., JORI, G., SONCIN, M., PRATESI, R., VANNI, U., RIHTER, B., KENNEY, M. E., and RODGERS, M. A. J., Photochem. Photobiol., 1994, 59, (3), 362–365.
  • Indium-111-labeled liposomes: quality and biodistribution in mice bearing human tumor xenografts. NAKAMURA, K., KUBO, A., KATAYAMA, M., HASHIMOTO, S., TAKATOKU, K., WAKU1, Y., and BANDO, K., Drug Delivery, 1993, 1, (1), 69–73.
  • Liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) promotes hemopoietic recovery in irradiated mouse. FEDOROCKO, P., ml. .7. Radiat. Biol., 1994, 65, (4), 465–475.
  • ESR study of order and dynamics in lecithin liposomes with high cholesterol content. COSTANZO, R., DE-PAOLI, T., IHLo, J. E., HAGER, A. A., FARACH, H. A., POOLE, C. P. JR., and KNIGHT, J. M., Spectrochim Ada, Part A, 1994, 50A, (2) 203–208.
  • The influence of ionic strength and lipid bilayer charge on the stability of liposomes. CARRION, F. J., DE-LA-MAZA, A., and PARRA, J. L.,j. Colloid, Interface Sci„ 1994, 164, (1), 78–87.
  • Amphiphilic peptides enhance the efficiency of liposome-mediated DNA transfection. KAMATA, H., YAGISAWA, H., TAKAHASHI, S., and HIRATA, H., Nucleic Acids Res., 1994, 22, (3) 536–537.
  • Liposome-entrapped PGE1 posttreatment decreases IL-1.alpha.-induced neutrophil accumu-lation and lung leak in rats. LEFF, J. A., BAER, J. W., KIRKMAN, J. M., BODMAN, M. E., SHANLEY, P. F., CHO, O. J., OSTRO, M. J., and REPINE, J. E.,.7. Appl. Physiol., 1994, 76, (1), 151–157.
  • Selected tissue distribution of liposomal methylprednisolone in rats. MisHINA, E. V., and JusKo, W. J., Res. Commun. Chem. Pathol. Pharmacol., 1994, 84, (1), 47–52.
  • ESR study of membrane perturbation and the lysis of liposomes induced by chlorpromazine. MORIMOTO, Y., HOSOKAWA, M., SAYO, H., and TAKEUCHI, Y., Chem. Pharm. Bull., 1994,42, (1), 123–129.
  • Toxicity of bupivacaine encapsulated into liposomes and injected intravenously: comparison with plain solutions. BOOGAERTS, J., DECLERCQ, A., LAFONT, N., BENAMEUR, H., AKODAD, E. M., DUPONT, J.-C., and LEGROS, F. J., Anesth. Analg. (New York), 1993, 76, (3), 553–555.
  • Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. HUANG, S. K., STAUFFER, P. R., HONG, K., Guo, J. W. H., PHILLIPS, T. L., HUANG, A., and PAPAHADJOPOULOS, D., Cancer Res., 1994, 54, (8), 2186–2191.
  • Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. WHARTON, S. A., BELSHE, R. B., SKEHEL, J. J., and HAY, A. J.,.7. Gen. virol., 1984, 75, (4), 945–948.
  • Sol-gel microsphere pelletization(SGMP): a powder-free advanced process for fabrication of ceramic nuclear fuel pellets. GANGULY, C., Bull. Mater. Sci., 1993, 16, (6), 509–522.
  • Polyhydroxamic microcapsules prepared from proteins: a novel type of chelating microcap-sules. HETTLER, D., ANGRY, M. C., and LEVY, M. C., 3. Microencapsulation, 1994, 11, (2), 213–224.
  • Microencapsulation with carrageenan-locust bean gum mixture by multiphase emulsification technique for sustained drug release. Suzuxi, S., and Lim, J. K. 3. Microencapsulation, 1994, 11, (2), 197–203.
  • Biological evaluation of acyclovir microcapsule suspension prepared by carbopol-gelatin coacervation. CHO. J. H., HAHN, Y. H., Yi, J. W., and CHOI, Y. W., Yakche Hakhoechi, 1993, 23, (3), 139–144.
  • Manganese-based liposomes. Comparative approaches. UNGER, E., FRITZ, T., SHEN, D. K., and Wu, G., Invest. Radiol., 1993, 28, (10), 933–938.
  • Pilocarpine hydrochloride liposomal ophthalmic drug delivery system. KHALIL, R. M., EL-NAHHAS, S. A., OMAR, S. M., and EL-RIDY, M. S., Egypt 3. Pharm. Sci., 1992, 33, (3–4), 667–678.
  • Optimization of microencapsulation of theophylline with Eudragits. Part II. Effect of' additives on microencapsulation of theophylline with Eudragits. BADAW, A. A., SHOUKRI, R. A., and EL-ZAINY, A. A., Egypt 3, Pharm, Sci,, 1992, 33, (3–4), 651–666.
  • Adriamycin loading and release characteristics of albumin-heparin conjugate microspheres. CREMERS, H. F. M., VERRIJK, R., NOTEBORN, H. P. J. M., KWON, G., BAE, Y. H., KIM, S. W., and FEIJEN, J., 3. Controlled Release, 1994, 29, (1–2), 143–155.
  • Hyaluronic acid ester microspheres as a nasal delivery system for insulin. ILLum, L., FARRAJ, N. F., FISHER, A. N., GILL, I., MIGLIETTA, M., and BENEDETTI, L. M., 3. Controlled Release, 1994, 29, (1–2), 133–141.
  • Targeting of liposomes to cells expressing CD4 using glycosylphosphatidylinositol-anchored gp120. Influence of liposome composition on intracellular trafficking. SCHREIER, H., MORAN, P., and CARAS, I. W., 3. Biol. Chem., 1994, 269, (12) 9090–9098.
  • Efficacy of albenazole administered orally is improved by encapsulation in liposomes. NEW, R. R. C., WEN, H., CRAIG, P. S., Zou, P. F., MERDAN, A., WANG, J. H., WANG, Y. H., WANG, P., and ZHANG, J. H., y. Controlled Release, 1994, 28, (1-3), 350–351.
  • Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist inhaler. TAKENAGA, M., NAKAGAWA, T., IGARASHI, R., and MIZUSHIMA, Y., y. Controlled Release, 1994, 28, (1-3), 344–345.
  • Screening candidate microsphere formulations by incubating in simulated digestive fluids. BAUGHMAN, R. A., HAAS, S., MILSTEIN, S., and SANTIAGO, N., 3. Controlled Release, 1994, 28, (1–3), 340–341.
  • Method for assessing the stability of proteinoid microspheres. BAUGHMAN, R. A., HAAS, S., MILSTEIN, S., and SANTIAGO, N., 3. Controlled Release, 1994, 28, (1–3), 338–339.
  • Effect of compression pressure on physical properties and dissolution characteristics of disintegrating tablets of propranolol micospheres. CHIAO, C. S. L., and PRICE, J. C., 3. Microencapsulation, 1994, 11, (2), 161–170.
  • Antitumor activity of free and liposome-entrapped annamycin, a lipophilic antibiotic with non-cross-resistance properties. Zou, Y., LING, Y. H., VAN, N. T., PRIEBE, W., and PEREZ, S. R., Cancer Res., 1994, 54, (6), 1479–1484.
  • Carbohydrate-mediated liposomal targeting and drug delivery. JONES, M. N., Adv. Drug Delivery Rev., 1994, 13, (3), 215–249.
  • Formation of the structure of the cement stone of well cement with ash microspheres from thermoelectric power station Bobov dol. 2. Investigation of the hydration products in the cement stone. LILKov, V., BECHEV, G., and KOLEV, K., Fiz-Khim. Mekh., 1992, 21, 41–48.
  • Studies on particle surface properties of emulsifier-free acrylate latexes with functional polymer microsphere. CHEN, G., and Ji, Q., Gongneng Gallia°, 1992, 23, (4), 211–216.
  • Microencapsulation of Lactococcus lactis subsp. cremoris. LARISCH, B. C., PONCELET, D., CHAMPAGNE, C. P., and NEUFELD, R. J., 3. Microencapsulation, 1994, 11, (2) 189–195.
  • Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. HARASHIMA, H., SAKATA, K., FUNATO, K., and KIWADA, H., Pharm. Res., 1994, 11, (3), 402–406.
  • The effects of membrane physical properties on the fusion of Sendai virus with human erythrocyte ghosts and liposomes. Analysis of kinetics and extent of fusion. CHEETHAM, J. J., NIR, S., JOHNSON, E., FLANAGAN, T. D., and EPAND, R. m., 3. Biol. Chem., 1994, 269, (7) 5467–5472.
  • Biodistributions of air-filled albumin microspheres in rats and pigs. WALDAY, P., TOLLESHAUG, H., GJOEN, T., KINDBF:RG, G. M., BERG, T., SKOTLAND, T., and HOLTZ, E., Biochem. 3., 1994, 299, (2), 437–443.
  • Preparation of the highly efficient polymer support for the solid-phase synthesis of DNA fragments based on microspheric silica Silochrome-2. DUBEY, I. Y., LJAPINA, T. V., GALKIN, A. P., and FEDORJAK, D. M., Biopolim Kletka, 1993, 9, (4), 26–31.
  • Microencapsulated human bone marrow cultures: a potential culture system for the clonal outgrowth of hematopoietic progenitor cells. LEVEE, M. G., LEE, G. M., PAEK, S. H., and PALSSON, B. C., Biotechnol. Bioeng., 1994, 43, (8), 734–739.
  • Preparation and characterization of ligand-modified labeled liposomes for solid phase immunoassays. JONES, M. A., SINGH, A., KILPATRICK, P. K., and CARBONELL, R. G., 1. Liposome Res., 1993, 3, (3), 793–804.
  • Quantitative determination of phosphatidylethanolamine and phosphatidylserine in lipo-somes and on HPTLC plates with o-phthalaldehyde. ZELLMER, S., and LASCH, J., Anal. Biochem., 1994, 218, (1), 229–231.
  • Steric immobilization of liposomes in chromatographic gel beads and incorporation of integral membrane proteins into their lipid bilayers. YANG, Q., and LUNDAHL, P., Anal. Biochem., 1994, 218, (1), 210–221.
  • Fluorometric analysis of liquid-crystalline to inverted hexagonal phase transition induced by diacylglycerol in liposomes. NAGANUMA, M., Hokkaido Igaku Zasshi, 1994, 69, (1) 65–71.
  • Magainin oligomers reversibly dissipate DELTA.mu.H + in cytochrome oxidase liposomes. JuRET1c, D., HENDLER, R. W., KAMP, F., CAUGHEY, W. S., ZASLOFF, M., and WESTERHOFF, H. V., Biochemistry, 1994, 33, (15), 4562–4570.
  • Microencapsulated insecticides-a promising new formulated product. ROSLAVTSEVA, S. A., Agrokhimiya, 1992, (10), 122–126.
  • Effect of pH on liposome fusion by alpha-latroxtoxin. TERLETSKAYA, Y. T., and TRIKASH, I. O., Biokhimiya (Moscow), 1994, 59, (3) 441–448.
  • Liposome-mediated gene transfer into human vascular smooth muscle cells. PICKERING, J. G., JEKANOWSKI, J., WEIR, L., TAKESHITA, S., LOSORDO, D. W., and ISNER, J. M., Circulation, 1994, 89, (1), 13–21.
  • Effect of adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expression. ASANO, T., FUJIMAKI, W., MCWATTERS, A., AN, T., MATSUSHIMA, K., and KLEINERMAN, E. S., Cancer Immunol. Immunother., 1993, 37, (6), 408–411.
  • Pharmacokinetics of methotrexate after intravenous and instramuscular injection of methotrexate-bearing neutral liposomes into rats. BAE, E. J., LEE, S. H., LEE, M. G., HWANG, S. J., and KIM, C. K.,.7. Clin. Pharm. Ther., 1993, 18, (6), 393–404.
  • Gene introduction into animal cells with fusogenic liposomes. NAKANISHI, M., ASHIHARA, K., SENDA, T., KONDO, T., and MAYUMI, T., jikken Igaku., 1994, 12, (3), 328–332.
  • Very high-Q whispering-gallery mode resonances observed on fused silica microspheres. COLLOT, L. V., LEFEVRE, S., BRUNE, M., RAIMOND, J. M., and HAROCHE, S., Europhys. Lett., 1993, 23, (5), 327–334.
  • Activation of human neutrophils by Arg-Gly-Asp-Ser immobilized on microspheres. KASUYA, Y., FUJIMOTO, K., MIYAMOTO, M., and KAWAGUCHI, H., y. Biomed. Mater. Res., 1994, 28, (3), 397–404.
  • Ibuprofen microcapsules: the effect of production variables on microcapsule properties. KRISTMUNDSDOTTIR, T., and INGVARSDOTTIR, K., Drug. Dev. Ind. Pharm., 1994, 20, (5), 769–778.
  • Efficient entrapment of amikacin and teicoplanin in liposomes. RAVAOARINORO, M., TOMA, E., AGBABA, O., and MORISSET, R., I. Drug. Targeting, 1993, 1, (3), 191–195.
  • Efficient encapsulation of proteins within liposomes for slow release in vivo. MEYER, J. WHITCOMB. L., and COLLINS, D., Biochem. Biophys. Res. Commun., 1994, 199, (2), 433–438.
  • Preparation of polyamide microcapsules having narrow size distributions. MURAMATSU, N., SHIGA, K., and KONDO, T., y. Microencapsulation, 1994, 11, (2), 171–178.
  • Formulation, preparation and dissolution characteristics of propranolol hydrochloride mierospheres. CHIAO, C. S. L., and PRICE, J. C.,.7. Microencapsulation, 1994, 11, (2), 153–159.
  • Sustained-release dosage form of nitrofurantoin. Part 1. Preparation of microcapsules and in vitro release kinetics. ERTAN, G., SARIGULLU, I., KARASULU, Y., ERCAKIR, K., and GUNERI, T., y. Microencapsulation, 1994, 11, (2), 127–135.
  • New preparation for oral administration of digestive enzyme. Lactase complex microcap-sules. WANG, X. L., and SHAO, J. Y., Biontater., Anil Cells, Immobilization Biotechnol., 1993, 21, (5), 637–646.
  • pH-sensitive liposomes: structural characterization and possible therapeutic applications. CESTARO, B., CAZZOLA, R., and VIANI, P.,.7. Liposome Res., 1993, 3, (3), 563–574.
  • A study of embolizing materials for chemo-embolization therapy of hepatocellular carci-noma: effects of chitin concentration on cis-diamminedichloroplatinum(H) albumin mierosphere properties and antitumor effect in VX2 hepatocellular carcinoma model rabbits. NISHIOKA, Y., KYOTANI, S., OKAMURA, M., OHNISHI, S., YAMAMOTO, Y., TANADA, S., and NAKAMURA, T., Biol. Pharm. Bull., 1993, 16, (11), 1136–1139.
  • Biodegradable microspheres for the parenteral administration of vitamin D3. CONTI, B., PAVANETTO, F., GENTA, I., and GANDINI, C., Acta Techol. Legis. Med., 1990, 1, (2), 101–112.
  • Microencapsulation studies on aminophylline involving spherical crystallization, spheroniza-tion and drug loading on to non-pareil seeds. BOLES, M. G., DEASY, P. B., and DONNELLAN, M. F., J. Microencapsulation, 1994, 11, (1), 55–67.
  • Preparation and characterization of liposomes containing a lipophilic cisplatin derivative for clinical use. PEREZ-SOLAR, R., FRANCIS, K., AL-BAKER, S., PILKIEWICZ, F., and KHoRHAR, A. R., J. Microencapsulation, 1994, 11, (1), 41–54.
  • Preparation and study of release kinetics of rosin pentaerythritol ester microcapsules. SHEOREY, D. S., and DORLE, A. K., y. Microencapsulation, 1994, 11, (1), 11–17.
  • Microencapsulation of mitomycin C for controlled delivery and targeting. WHATELEY, T. L., ELEY, J. G., CROSSAN, 1., and DEASY, P. B., J. Controlled Release, 1994, 28, (1-3), 345–355.
  • Stability and mode of action of AmBisome (liposomal amphotericin B). PROFITT, R. T., ADLER-MOORE, J., Fuji', G., SATORIUS, A., LEE, M. J. A., and BAILEY, A., J. Controlled Release, 1994, 28, (1-3), 342–343.
  • Recent clinical studies on lipo-PGE1 and lipo-PG12: PGE1 and PG12 incorporated in lipid microspheres, for targeted delivery. MIZUSHIMA, T., TOYOTA, T., OKITA, K., and OHTOMO, E., y. Controlled Release, 1994, 28, (1-3), 243–249.
  • Drug delivery using biodegradable microspheres. OKADA, H., YAMAMOTO, M., HEYA, T., INOUE, Y., KAMEI, S., OGAWA, Y, and TOGUCHI, H., y. Controlled Release, 1994, 28, (1-3), 121–129.
  • Assessment of biodegradability of polymeric microspheres in vivo: poly(DL-lactic acid), poly(L-lactic acid) and poly(DL-lactide-co-glycolide) microspheres. OH, I. J., OH, J. Y., and LEE, K. C. Arch. Pharmacal. Res., 1993, 16, (4), 312–317.
  • Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. JEPSON, M. A., SIMMONS, N. L., O'HAGAN, D. T., and HIRST, B. H., J. Drug Targeting, 1993, 1, (3), 245–249.
  • Hepatic uptake and tissue distribution of liposomes: influence of vesicle size. Yu. H. Y., and Liu, R. F., Drug Dev. Ind. Pharm., 1994, 20, (4), 557–574.
  • Vasoactive intestinal peptide encapuslated in liposomes; effects on systemic arterial blood pressure. GAO, X., NODA, Y., RUBINSTEIN, 1., and PAUL, S., Life Sci., 1994, 54, (15), PL247-PL252.
  • Interaction of ciprofloxacin loaded liposomes with Pseudomonas aeruginosa cells. NICHOLOV, R., KHOURY, A. E., BRUCE, A. W., and DiCosmo, F., Cells Mater., 1993, 3, (3), 321–326.
  • Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice. AGARWAL, A., KANDEAL, H., GUPTA, H. P., SINGH, N. B., and GUPTA, C. M., Antimicrob. Agents Chemother., 1994, 38, (3), 588–593.
  • Microencapsulation by coacervation of poly(lactide-co-glycolide):1. Physicochemical charac-teristis of the phase separation process. STASSEN, S., NIHANT, N., MARTIN, V., GRANDfiLS, C., JEROME, R., and TEYSSIE, P., Polymer, 1994, 35, (4), 777–785.
  • Lipid peroxidation of L-alpha-phosphatidylcholine from fresh egg yolk and from soybean during Liposome perparation and storage. MEMOLI, A., PALERMITI, L. G., TRAVAGLI, V., and ALHAIQUE, F., J. Liposome Res., 1993, 3, (3), 697–706.
  • Liposome internalization by isolated rat hepatocytes. DINI, L., CRETI, P. Di, G. A., DI, M. L., FALASCA, L., LENTINI, A., MOSSA, G., and FINAZZI, A. A.,Y. Liposome Res., 1993, 30(3), 649–661.
  • Preclinical studies with doxorubicin encapsulated in polyethylene glycol-coated liposomes. GABIZON, A. A., PAPPO, O., GOREN, D., CHEMLA, M., TZEMACH, D., and HOROWITZ, A. T., J. Liposome Res., 1993, 3, (3), 517–528.
  • Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. LITZINGER, D. C., BUITING, A. M. J., ROOIJEN, N. VAN, and HUANG, L., Biochim. Biophys. Acta, 1994, 1190, (1), 99–107.
  • Controlled release of anticancer drug methotrexate from biodegradable gelatin micro-spheres. NARAYANI, R., and RAO, K. P., J. Microencapsulation, 1994, 11, (1), 69–77.
  • Microencapsulation within crosslinked polyethyleneimine membranes. PONCELET, D., ALEXAKIS, T., PONCELET DE SMET, B., and NEUFELD, R. J., y. Microencapsulation, 1994, 11, (1), 31–40.
  • Enhanced antitumor activity and reduced toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice, TAKENAGA, M., IGARASHI, R., Tsuji, H., and MIZUSFIIMA, Y., ypn. J. Cancer Res., 1993, 84, (10), 1078–1085.
  • Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encap-sulated gene: cytocidal effect on glioma transplanted into nude mouse brain.YAG1, K., HAYASHI, Y., ISHIDA, N., OHBAYASHI,. M., OHISHI, N., MIZUNO, M., and YOSHIDA, J., Biochem. Mol. Biol. Int., 1994, 32, (1), 167–171.
  • Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8 + cytotoxic T cells. LIPFORD, G. B., WAGNER, H., and HEEG, K., Vaccine, 1994, 12, (1), 73–80.
  • Liposomes and liposome-like vesicles in perfluorocarbon emulsions. MEINERT, H., REUTER, P., ROEHLKE, W., CAMBON, A., SZOENYI, S., and GAYSINSKI, M., J. Fluorine Chem., 1994, 66, (2), 203–207.
  • Biodegradable microspheres for the delivery of oral vaccines. MESTECKY, J., MOLDOVEANU, Z., NOVAK, M., HUANG, W. Q., GILLEY, R. M., STAAS, J. K., SCHAFER, D., and COMPANS, R. w., .7. Controlled Release, 1994, 28, (1–3), 131–141.
  • Targeted delivery of diagnostic agents by surface-modified liposomes. TORCHILIN, V. P., TRUBETSKOY, V. S., MI LSHTEYN, A. M., CANILLO, J., WOLF, G. L., PAPISOV, M. I., BOGDANOV, A. A., NARULA, J., KHAW, B., A., and OMELYANENKO, V. G., y. Controlled Release, 1994, 28, (1-3), 45–58.
  • Liposomes as carriers for drugs and antigens: approaches to preserve their long term stability. CROMMELIN, D. J. A., GRIT, M., TALSMA, H., and ZUIDAM, N. J., Drug Dev. Ind. Pharm., 1994, 20, (4), 547–556.
  • Liposomes and skin tolerance. CACCIAGUERRA, M. G., and PUDDU, P.,.7. Liposome Res., 1993, 3, (3), 529–533.
  • Targeted delivery of drugs and DNA with liposomes. HUANG, L., KLIBANOV, A. L., MORI, A., and GAO, X., y. Liposome Res., 1993, 3, (3), 505–515.
  • Immunologic presentation of liposome antigens. ALVING, C. R.,.7. Liposome Res., 1993, 3, (3), 493–504.
  • Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. ADLER-MOORE, J. P., and PROFfiTT, R. T., J. Liposome Res., 3, (3), 429–450.
  • Industrial production and quality control of two liposome gels: size, size distribution and stability. NARDI, A., FILECCIA, P., DIN, L., MELINO, G., and GUARNIERI, D., y. Liposome Res., 1993, 3, (3), 535–541.
  • Effect of microencapsulation on the properties of Mm Ni34C0.5Mno.4A10.3 hydrogen storage alloy. ZHANG, Y., CHEN, J., CHEN, Y., and WANG, D., Wuji Huaxue Xuebao, 1993,9, (4), 431–433.
  • Dielectric measurement of a single sub-millimeter size microcapsule. ASAMI, K., and ZHAO, K. S., Colloid Polym. Sci., 1994, 272, (1), 64–71.
  • Arm-number effect of core-shell type polymer microsphere: 1. Control of arm-number of microsphere. SATIO, R., KAWACHI, N., and IsFilzu, K., Polymer, 1994, 35, (4), 866–871.
  • Study of the interfacial polycondensation of isocyanate in the preparation of benzalkonium chloride loaded microcapsules. PENSE, A. M., VAUTHIER, C. and BENOIT, J. P., Colloid Polym. Sci., 1994, 272, (2), 211–219.
  • Carbon dioxide hydration with liposomes entrapping carbonic anhydrase. ANNESINI, M. C., Di, G. L., DI, M. L., FINAZZI, A.-A., SERAfiNO, A. L., and MOSSA, G., y. Liposome Res., 1993, 3 (3), 639–648.
  • Investigations of the oxygen supply in calcium alginate beads and microcapsules loaded with Penicilliurn raistrickii using a microelectrode. IRRGANG, S., BAUMGAERTL, H., SCHLOSSER, D., ZIMELKA, W., and SCHMAUDER, H. P., y. Basic Microbiol., 1993, 33, (5), 311–321.
  • Elimination of macrophages by liposome-encapsulated dichloromethylene diphosphonate suppresses the endotoxin-induced priming of Kupffer cells. BAuTisTA, A. P., SKREPNIK, N., NIESMAN, M. R.., and BAGBY, G. J.,7. Leukocyte Biol., 1994, 55, (3), 321–327.
  • Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats. MOGHIMI, S. M., HEDEMAN, H., CHRISTY, N. M., ILLUM, L., and DAVIS, S. S.,Leukocyte Biol., 1993, 54, (6), 513–517.
  • Cytokines in liposomes: preliminary studies with IL-1- IL-2, IL-6. GM-CSF and interferon-gamma. ANDERSON, P. M., HANSON, D. C., HASZ, D. E., HALET, M. R., BLAZAR, B. R., and OCHOA, A. C., Cytokine (Philadelphia), 1994, 6, (1), 92–101.
  • Development of liposome immunosorbent assay for human interferon-gamma. RONGEN, H. A. H., VAN DER HORST, H. M., HUGENHOLTZ, G. W. K., BULT, A., VAN BENNEKOM, W. P., and VAN DER MEIDE, P. H., Anal. Chim. Acta., 1994, 287, (3), 191–199.
  • Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. PIGAULT, C., FOLLENIUS, W. A., SCHMUTZ, M., FREYSSINET, J. M., and BRISSON, A., y. Mol. Biol., 1994, 236, (1), 199–208.
  • The thermotropic phase behaviors of artificial phospholipid liposomes incorporated with soyasaponin. Kim, N. H., and ROH, S. B., Han'guk Yongyang Siklyong Hakhoechi, 1993,22, (33), 323–327.
  • Enhanced Dynamic Stability of Macrocyclic and Bolaamphiphilic Macrocyclic Lipids in Liposomes. Moss, R. A., Li, G., and LI, J. M.,.7. Am. Chem. Soc., 116, (2), 805–806.
  • Phospholipase-like myotoxins induce rapid membrane leakage of non-hydrolyzable ether-lipid liposomes. PEDERSEN, J. Z., DE ARCURI, B. F., MORERO, R. D., and RUfiNI, S., Biochim. Biophys. Acta, 1994, 1190, (1), 177–180.
  • Iron-induced lipid peroxidation kinetics in liposomes: the role of surface Fe2 + concentration in switching the reaction from acceleration to decay. DRIOMINA, E. S., SHAROV, V. S., and VLADIMIROV, Y. A., Free Radical Biol. Med., 1993, 15, (3), 239–247.
  • Reconstitution in liposomes of a mu-opioid binding protein purified to homogeneity from bovine striatal membranes. GIOANNINI, T. L., FAN, L. Q., HYDE, L., OFRI, D., HILLER, J. M., and SIMON, E. J., Regul. Pept., 1994, (Suppl. 1), S55–S56.
  • Partition coefficients of omega-phenylalkanols between water and liposome membranes of phospholipids. KAWAMURA, H., MANABE, M., YAMASHITA, R., and KAGIMOTO, H., 9. Solution Chem., 1994, 23, (1), 85–100.
  • Antiproliferative effects of free and liposome-encapsulated retinoic acid in a squamous carcinoma model: monolayer cells and multicellular tumor spheroids. SACKS, P. G., OKE, V., and MEHTA, K., Y. Cancer Res. Clin. Oncol., 1992, 118, (7), 490–496.
  • Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M intracellular complex in human macrophages. ONYEJI, C. O., NIGHTINGALE, C. H., NICOLAU, D. P., and QUINTILLIANI, R., Antimicrob. Agents Chemother., 1994, 38, (3), 523–527.
  • Evaluation of the antischistosomal effect of praziquantel in a liposomal delivery system in mice. AMMAR, H. O., EL RIDY, M. S., GHORAB, M., and GHORAB, M. M., Int. 9. Pharm., 1994, 103, (3), 237–241.
  • Microspheric silica gels for highly effective liquid chromatography. KABULOV, B. D., GRABOVSKAYA, T. A., and ZALYALIEVA, S. V., Zh. Fiz. Khim., 1993, 67, (10), 2070–2072.
  • Transplantation of microcapsules (a potential bio-artificial organ): biocompatibility and host reaction. COLE, D. R., WATERFALL, M., MCINTYRE, M., and BAIRD, J. C., y. Mater. sci. Mater. Med., 1993, 4, (5), 437–442.
  • Which liposomes to bypass multidrug resistance? A study of doxorubicin-loaded vesicles. HENRY, T. N., LALANNE, J., and DECOUT, A., 9. Liposome Res., 1993, 3, (3), 753–766.
  • Urease-loaded liposomes as detoxifying microreactors: effect of ammonia accumulation on enzyme kinetics. Clocl, F., and LAVECCHIA, R., y. Liposome Res., 1993, 3, (3), 725–735.
  • Determination of free amino group content of serum albumin microcapsules: IL Effect of variations in reaction time and in terephthaloyl chloride concentration. EDWARDS, L. F., ANDRY, M. C., and LEVY, M. C., Int. 9. Pharm., 1994, 103, (3), 253–257.
  • Entrapment of proteins in poly(L-lactide) microspheres using reversed micelle solvent evaporation. HAYASHI, Y., YOSHIOKA, S., Aso, Y., Po, A. L. W., and TERAO, T., Pharm. Res., 1994, 11, (2), 337–340.
  • Microencapsulation of nitrofurantoin by coacervation using certain polymeric materials. ALY, A. M., SALEH, S. I., AHMED, S. M., ABDEL RAHAMAN, S. I., and ABOUTALEB, A. E., Bull. Pharm. Sci. (Assiut Univ.), 1993, 16, (1), 73–87.
  • Liposomal encapsulation of beta-galactosidase: effect of buffer molarity, lipid composition and stability in milk. CHAWAN, C. B., PENMETSA, P. K., VEERAMACHANENI, R., and RAO, D. R., 9. Food Biochem., 1993, 16, (6), 349–357.
  • Microencapsulation of vitamin C by the solvent vaporation process. ZHU, R., XUE, F., YANG, L., and ZHAO, D., Gongneng Gaofenzi Xuebao, 1992, 5, (3), 175–180.
  • Incorporation of alpha-tocopherol in liposome promotes the retention of liposome-encapsu-lated glutathione in the rat lung. SUNTRES, Z. E., and SHEK, P. N., y. Pharm. Pharmacol., 1994, 46, (1), 23–28.
  • Glutaraldehyde crosslinked bovine casein microspheres as a matrix for the controlled release of theophylline: in vitro studies. LATHA, M. S., and JAYAKRISHNAN, A., y. Pharm. Pharmacol., 1994, 46, (1), 8–13.
  • Subcutaneous administration of sterically stabilized (stealth) liposomes in an effective sustained release system of 1-beta-D-arabinofuranosylcytosine. ALLEN, T. M., HANSEN, C. B., and PELIOWSKI, A., Drug Delivery, 1993, 1, (1), 55–60.
  • Targeting of liposomes to the blood-brain barrier in rats. MIcimus, M. J., GREIG, N. H., TUNG, J., and RAPOPORT, S. I., Drug Delivery, 1993, 1, (1), 21–26.
  • Influence of the main phospholipid (MPL) from Thermoplasma acidophilum and of liposomes from IVIPL On living cells: cytotoxicity and mutagenicity. FREBLEBEN, H. J., NEissEv, C., HARTMANN, M., RUDOLPH, P., GECK, P., RING, K., and MUELLER, W. E. G., 9. Liposome Res., 1993, 3, (3), 817–833.
  • Studies on the effects of free and liposomized albendazole on infections of Mesocestoides corti tetrathyridia (Cestoda: Cyclophyllidea) in laboratory mice. HRCKOVA, G., and VELEBNY, S., Comp. Biochem. Physiol. C.: Pharmacol. Toxicol. Endocrinol., 1994, 107C, (1), 71–77.
  • The influence of particle size of liposomes on the deposition of drug into skin. DU PLESSIS, J., RAMACHANDRAN, C., WEINER, N., and MULLER, D. G., Int. y. Pharm., 1994, 103, (3), 277–282.
  • Calorimetric studies on tolmetin release from poly(DL-lactide) microspheres to lipid model membrane. CASTELLI, F., CONTI, B., PUGLISI, G., CONTE, U., and MAZZONE, G., Int. y. Pharm., 1994, 103, (3), 217–223.
  • Effects of cholesterol in the miscibility of synthetic glucosamine diesters in lipid bilayers and the entrapment of superoxide dismutase into the positively charged liposomes.
  • MIYAJIMA, K., KOMATSU, H., SUN, C., AOKI, H., HANDA, T., Xu, H., Fuji, K., and OKADA, S., Chem. Pharm. Bull., 1993, 41, (11), 1889–1894.
  • Effect of liposomally encapsulated MTX-DMPE conjugates upon TNF alpha and PGE2 release by lipopolysaccharide stimulated rat peritoneal macrophages. WILLIAMS, A. S., TOPLEY, N., and WILLIAMS, B. D., Biochim. Biophys. Acta., 1994, 1225, (2), 217–222.
  • Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice. GILBERT B. E., WYDE, P. R., LOPEZ, B. G., and WILSON, S. Z., Antimicrob. Agents. Chemother., 1994, 38, (2), 356–359.
  • Liposome-encapsulated hemoglobin: a red blood cell substitute. ZHENG, S., BEISSINGER, R., SHERWOOD, R. L., McCoRmIcK, D. L., LASIC, D. D., and MARTIN, F. J., y. Liposome Res., 1993, 3, (3), 575–588.
  • Enhanced protection against respiratory influenza A infection in mice by liposome-encapsu-lated antibody. WoNG, J. P., STADNYK, L. L., and SARAVOLAC, E.G., Immunology, 1994, 81,(2), 280–284.
  • Potential of polymer microencapsulation technology for vaccine innovation. MORRIS, W., STEINHOFF, M. C., and RUSSELL, P. K., Vaccine, 1994, 12, (1), 5–11.
  • Amphotericin B formulated in liposomes and lipid based systems: a review. SZOKA, F. C. JR., and TANG, M., J. Liposome Res., 1993, 3 (3), 363–375.
  • Application of microspheres for manufacturing mucosal vaccines. YAMAMOTO, M., and KIYONO, H., Med. Immunol., 1993, 26, (6), 621–626.
  • Small packages that deliver big ideas: an inside look into microcapsule technology. TURNER, B., and LEVEY, L., Spec. Publ.-R. Soc. Chem., 1993, 138 (Encapsulation and Controlled Release), 98–101.
  • Liposomes: a promising future for dermatocosmetology and clinical dermatology. RASKOVIC, D., and PIAZZA, P., y. Liposome Res., 1993, 3, (3), 737–751.
  • Mode of action of topically applied liposomes in dermatology and cosmetics. SCHUBERT, R., Joos, M., DEICHER, M., and LASCH, J., Proc. MoBBEL, 1992, 6, 20–32.
  • Role of physical heterogeneity in the interpretation of small-scale laboratory, and field observations of bacteria, microbial-sized microsphere,, and bromide transport through aquifer sediments. HARVEY, R. W., KINNER, N. E., MACDONALD, D., METGE, D. W., and BUNN, A., Water Resour. Res., 1993, 29, (8), 2713–2721.
  • Formation and properties of aerocolloidal TiO2-coated microspheres produced by alkoxide droplet reaction. IA. W., RASSAT, S. D., Foss, W., R., and DAVIS, E. J., J. Colloid Interface Sci., 1994, 162, (2), 267–278.
  • Glass microspheres. Use, properties, and manufacture. Review. Bunov, V. V., and EGOROVA, L. S., Steklo Keram, 1993, (7), 2–5.
  • Industrial microencapsulation: polymers for microcapsule walls. FINCH, C. A., Spec. Publ.-R. Soc. Chem., 1993, 138 (Encapsulation and Controlled Release), 1–12.
  • Electrophorectic behavior of polyA-graft-polyB-type microcapsules. AOYANAGI, O., MURAMATSU, N., OHSHIMA, H., and KONDO, T., y. Colloid Interface Sci., 1994, 162, (1), 222–226.
  • Inverse, photosenstive microencapsulation: interfacial polyaddition, interfacial polyconden-sation, microencapsulation, photodegradation, and release measurements. NUYKEN, O., STEBANI, J., and LANG, A., Vysokomol Soedin (Ser. A, Ser. B), 1993, 35, (11), 1183–1189.
  • Photophysics and photochemistry of a laser-manipulated polymer microsphere. MASUHARA, H., KITAM URA, N., M SAWA, H., SASAKI, K., and KOSHIOKA, M., Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1992, 33, (1), 850.
  • The effect of liposome encapsulation of chymosin derived by fermentation on Manchego cheese ripening. PICON, A., GAYA, P., MEDINA, M., and NUNEZ, M., J. Dairy Sci., 1994, 77, (1), 16–23.
  • Studies on lipid oxidation in fish phospholipid liposomes. RAMANATHAN, L., DAS, N. P., and Li, Q. T., Biol. Trace Elem. Res., 1994, 40, (I), 59–70.
  • Microencapsulation of yeast cells in the calcium alginate membrane. CHEONG, S. H., PARK, J. K., Kim, B. S., amd CHANG, H. N., Biotechnol. Tech., 1993, 7, (12), 879–884.
  • Intracellular processing of hapten-modified protein for MHC class presentation: Cytoplasmic delivery by pH-senstitive liposomes. MARTIN, S., NIEDERMANN, G., LEIPNER, C., EICHMANN, K., and WELTZIEN, H. U., Immunol. Lett., 1993, 37, (2-3), 97–102.
  • Mechanism of liposome adjuvanticity: An in vivo approach. FORTIN, A., and THERIEN, H. M., Immunobiology (Stuttgart), 1993, 188, (3), 316–322.
  • Liposomes as models in membrane associated antigen interactions. RAJU, D. B., Indian Drugs, 1994, 31, (1). 1–8.
  • On the structure of electrical double layer of IgG immobilized on polystyrene microspheres. GALISTEO, G. F., MOLEON, B. J. A., and HIDALGO, A. R., y. Biomater. Sci. Polym. Ed., 1993, 4, (6), 631–641.
  • Correlation between microwave-induced lipid peroxidation and liposome leakage. BABINCOVA, M., Z. Naturforsch, C. Biosci, 1994, 49, (1-2), 139–140.
  • Synthesis of NAD polystyrene microspheres and application as a carrier of glucoamylase immobilization. Omi, S., KANEKO, K., TAKESUE, M., TSUJIMURA, H., SATOH, A., and Iso, M., J. Appl. Polym. Sci., 1994, 51, (7), 1239–1249.
  • Interaction of bovine erythrocyte spectrin with aminophospholipid liposomes. MICHALAK, K., BOBROWSKA, M., and SIKORSKI, A. F., Gen. Physiol. Biophys., 1993, 12, (2), 163–170.
  • Location, antioxidant and recycling dynamics of alpha-tocopherol in liposome membranes. FUKUZAWA, K., IKEBATA, W., and SOHMI, K., y. Nutr. Sci. Vitaminol., 1993, 39, (Suppl.), S9–522.
  • Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies. BALSARI, A. L., MORELLI, D., MENARD, S., VERONESI, U., and COLNAGHI, M. I., FASEB y., 1994, 8, (2), 226–230.
  • Distearoyl phosphatidylglycerol liposomes improve surface and transport properties of CF mucus. GIROD-DE-BENTZMANN, S., PIERROT, D., FUCHEY, C., ZAHM, J. M., MORANCAIS, J. L., and PUCHELLE, E., Eur. Respir. y., 1993, 6, (8), 1156–1161.
  • Liposomal muramyl tripeptide up-regulates interleukin-l-alpha, interleukin-l-beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. ASANO, T., MCWATTERS, A., AN, T., MATSUSHIMA, K., and KLEINERMAN, E. S., J. Pharmacol. Exp. Ther., 1994, 268, (2), 1032–1039.
  • Antiproliferative effects of free and liposome-encapsulated retinoic acid in a squamous carcinoma model: monolayer cells and multicellular tumor spheroids. SACKS, P. G., OKE, V., and MEHTA, K., y. Cancer Res. Clin. Oncol., 1993, 119, (7), 490–496.
  • Treatment of systemic candidiasis in a neutropenic murine model (by) using immunoglobulin G bearing liposomal amphotericin B. BELAY, T., HOSPENTHAL, D. R., ROGERS, A. L., and PATTERSON, M. J., Mycopathologia, 1993, 123, (1), 9–17.
  • Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis. WEISS, R. C., Cox, N. R., and MARTINEZ, M. L., Res. Vet. Sci., 1993, 55, (2), 162–172.
  • Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus. KAKIDANI, H., WATARAI, S., ONUMA, M., TOMOCHIKA, K., and YASUDA, T., Microbiol. Immunol., 1993, 37, (9), 713–720.
  • Neoglycoprotein conjugated liposomes as macrophage specific drug carrier in the therapy of leishmaniasis. KOLE, L., SAKAR, J., MAHATO, S. B., and DAs, P. K., Biochem. Biophys. Res. Commun., 1994, 200, (1), 351–358.
  • Tailoring liposomes for cancer drug delivery: from the bench to the clinic. GABIZON, A., Ann. Biol. Clin. (Paris), 1993, 51, (9), 811–813.
  • Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics. PRICE, C.:HORTON, J. W., and BAXTER, C. R., Surgery, 1994, 115, (4), 480–487.
  • Comparison of absorption of aqueous lidocaine and liposome lidocaine following topical application on rabbit vessels. Hou, S. M., and Yu, H. Y.J. Orthop. Res., 1994,12, (2), 294–297.
  • Location, antioxidant and recycling dynamics of alpha-tocopherol in liposome membranes. FUKUZAWA, K., I KEBATA, W., and SOHMI, K., J. Nutr. Sci. Vitaminol. (Tokyo), 1993, 39 (Supp.), S9–22.
  • Clinical pharmacology of pancreatic enzymes in patients with cystic fibtosis and in vitro performance of microencapsulted formulation. KRAISINGER, M., HOCHHAUS, G., STECENKO, A., BOWSER, E., and HENDELES, L., J. Clin. Pharmacol., 1994, 34, (2), 158–166.
  • Method for the quantification of alginate in microcapsules. HALLE, J. P., LANDRY, D., FOURNIER, A., BEAUDRY, M., and LEBLOND, F. A., Cell Transplant, 1993, 2, (5), 429–436.
  • Na3(B2OH17HN3): synthesis and liposomal delivery to murine tumors. FEAKES, D. A., SHELLY, K., KNOBLER, C. B., and HAWTHORNE, M. F., Proc. Natl. Acad. Sci., USA, 1994, 91, (8), 3029–3033.
  • Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma. BOGNER, J. R., KRONAWITTER, U., ROLINSKI, B., TRUBENBACH, K., and GOEBEL, F. D., J. Acquir. Immune Defic. Syndr., 1994, 7, (5), 463–468.
  • Unusal low proton permeability of liposomes prepared from the endogenous myelin lipids. DIAZ, R. S., and MONREAL, J., J. Neurochem., 1994, 62, (5), 2022–2029.
  • Liposome immunoassay (LIA) for gentamicin using phospholipase C. KIM, C. K., and PARK, K. M., J. Immunol. Methods., 1994, 170, (2), 225–231.
  • Enchanced protection against respiratory influenza A infection in mice by liposome-encapsu-lated antibody. WoNg, J. P., STADNYK, L. L., and SARAVOLAC, E. G., Immunology, 1994,81, (2), 280–284.
  • Isolation and characterization of addition products of alpha-tocopherol with peroxyl radicals of dilinoleoylphosphatidylcholine in liposomes. YAMAUCHI, R., YAGI, Y., and KATO, K., Biochim. Biophys. Acta, 1994, 1212, (1), 43–49.
  • Liposome-complement interactions in rat serum: implications for liposome survival studies. DEVINE, D. V., WONG, K., SERRANO, K., CHONN, A., and CULL1S, P. R., Biochim. Biophys. Acta, 1994, 1191 (1) 43–51.
  • Study by EPR of structural modifications on liposomes induced by two metabolites of modafinil. ABEL COINDOZ, C., VEZIN, H., DAVELOOSE, D., ROUSSELL, B., and VIRET, J., Ann. Pharm. Fr., 1993, 51, (4), 197–204.
  • The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome. FREISE, C. E., Liu, T„ HONG, K., OSORIO, R. W., PAPAHADJOPOULOS, D., FERRELL, L., ASCHER, N. L., and ROBERTS, J. P., Transplantation, 1994, 57, (6), 928–932.
  • Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasi: a multi-centre trial. DAVIDSON, R. N., DI MARTINO, L., GRADONI, L., GIACCHINO, R., Russo, R., GAETA, G. B., PEMPINELLO, R., SCOTT, S., RAIMONDI, F., CASCIO, A., et al., Q. J. Med., 1994, 87, (2), 75–81.
  • Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. GAO, X. P., NODA, Y., RUBINSTEIN, I., and PAUL, S., Life-Sci., 1994, 54, (15), PL247–252.
  • Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. WFIARTON, S. A. BELSHE, R. B., SKEHEL, J. J., and HAY, A. J., J. Gen. Virol., 1994, 75, (Pt. 4), 945–948.
  • Study on compound levonorgestrel microspheres. Guo, R., and Lu. B., Hua Hsi I Ko Ta Hsueh Hsueh Pao, 1993, 24, (4), 376–380.
  • Liposome-bound prostaglandin El often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. WILLERSON, J. T. YAO, S. K., MCNATT, J., Cut, K., ANDERSON, H. V., SWENSEN, C., OSTRO, M., and Bum, L. M., Circulation, 1994, 89,(4), 1786–1791.
  • Repeated transplantation of microencapsulated hepatocytes for sustained correction of hyperbilirubinemia in Gunn rats. DIXIT, V., ARTHUR, M., and GITNICK, G., Cell Transplant, 1992, 1, (4), 275–279.
  • Liposome-like particles isolated from human atherosclerotic plaques are structrually and compositionally similar to surface remnants of triglyceride-rich lipoproteins. CHUNG, B. H., TALUS, G., YALAMOOR1, V., ANANTHARAMA1AH, G. NI., and SEGREST, J. P., Arterioscler. Thromb., 1994, 14, (4), 622–635.
  • Studies on lipid oxidation in fish phospholipid liposomes. RAMANATHAN, L., DAS, N. P., and Li, Q.- T., Biol. Trace. Elem. Res., 1994, 40, (1), 59–70.
  • Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 rix1INA in CaSki Cells. LAPPALAINEN, K., URTTI, A., .IAASKELAINEN, I., SYRJANEN, K., and SYRJANEN, S., Antiviral Res., 1994, 23, (2), 119–130.
  • Effects of incubation with liposomes at different temperatures on cultured melanoma cells (M14). ARANCIA, G., CALCABRINI, A., MATARRESE, P., MARCOCCI, L., PIETRANGELL P., and MONDOVI, B., Int. y. Hyperthermia, 1994, 10, (1), 101–114.
  • The H( + )-ATPase from reticulocyte endosomes reconstituted into liposomes acts as an iron transporter. Li, C. Y., WATKINS, J. A., and GLASS, J., J. Biol. Chem., 1994, 269, (14), 10242–10246.
  • The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras. GHOSH, S., XIE, W. Q., QUEST, A. F., MABROUK, G. M., STRUM, J. C., and BELL, R. M., y. Biol. Chem., 1994, 269, (13), 10000–10007.
  • Immunologic isolation of transplanted islets of Langerhans: microcapsules with defined molecular limits. KLOCK, G., SIEBERS, U., PFEFFERMANN, A., SCHMITT, J., HOUBEN, R., FEDERLIN, K., and ZIMMERMANN, U., Immun. Infekt., 1993, 21, (6), 183–184.
  • Metabolic activity and proliferation of CHO cells in hydroxyethyl methacrylate-methyl methacrylate (HEMA-MMA) microcapsules. ULUDAG, H., and SEFTON, M. V., Cell Transplant, 1993, 2, (2), 175–182.
  • In vitro anti-human cytomegalovirus activity of liposome-encapsulated foscarnet. GUMBEL, H. O., RUCKERT, D. G., CINATL, J., RABENAU, H., DOERR, H. W., and OHRLOFF, C., Ger. J. Ophthalmol., 1994, 3, (1), 5–8.
  • Potent and reversible interaction of silver with pure Na, K-ATPase and Na, K-ATPase-lipo-somes. HUSSAIN, S., MENEGHINI, E., MOOSMAYER, M., LACOTTE, D., and ANNER, B. M., Biochim. Biophys. Acta, 1994, 1190, (2), 402–408.
  • Hepatic intra-arterial administration of doxorubicin and degradable starch microspheres. A pharmacokinetic study in the rat. JOHANSSON, C. J., TEDER, H., GRONQUIST, L., and GUNNARSSON, P.O., Acta Oncol., 1994, 33, (I), 39–42.
  • Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide. MELISSEN, P.M., VAN VIANEN, W., and BAKKER-WOUDENBERG, I. A., Antimicrob. Agents Chemother., 1994, 38, (1), 147–150.
  • Acoustical investigation of the liposome-saccharide interaction. BABINCOVA, M., and HIANIK, T., Acta Biochim. Pol., 1993, 40, (4), 483–486.
  • Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. PHILIP, R., BRUNETTE, E., KLINSKI, L., MURUGESH, D., MCNALLY, M. A., UCAR, K., ROSENBI.ATT, J., OKARMA, T. B., and LEBKOWSKI, J. S., MO/. Cell Biol., 1994, 14, (4), 2411–2418.
  • Incorporation of alphaxalone into different types of liposomes. DEAN, T. P., and HIDER, R. c., J. Pharm. Pharmacol., 1993, 45, (11), 990–992.
  • Albumin microspheres as a drug delivery system for dexamethasone: pharmaceutical and pharmacokinetic aspects. DILOVA, V., and SHISHKOVA, V., J. Pharm. Pharmacol., 1993, 45, (11), 987–989.
  • Analogues of tetramethylpyrazine affect membrane fluidity of liposomes: relationship to their biological activities. NIE, S. Q., MAJARAIS, I., KWAN, C. Y., and EPAND, R. M., Ear. J. Pharmacol., 1994, 266, (1), 11–18.
  • Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. ToLLEMAR, J., RINGDEN, O., ANDERSSON, S., SUNDBERG, B., LJUNGMAN, P., and TYDEN, G., Bone Marrow Transplant, 1993, 12, (6), 577–582.
  • Bovine and human endothelial cell growth on collagen microspheres and their infection with the rickettsia Cowdria ruminantium: prospects for cells and vaccine production. TOTTE, P., BLANKAERT, D., MARIQUE, T., KIRKPATRICK, C., VAN VOOREN, J. P., and WERENNE, J., Rev. Elev. Med. Vet. Pays. Trop., 1993, 46, (1-2), 153–156.
  • Radioactive microsphere validation of a volume localized continuous saturation perfusion measurement. WALSH, E. G., MINEMATSU, K., LEPPO, J., and MOORE, S. C., Magn. Reson. Med., 1994, 31, (2), 147–153.
  • Effect of lanthanide ions on the phase behavior of dipalmitoylphosphatidylcholine multilamel-lar liposomes. Li, X. M., ZHANG, Y. F., NI, J. Z., CHEN, J. W., and HWANG, F.,Y. Inorg. Biochem., 1994, 53, (2), 139–149.
  • Liposomal amphotericin-B (AmBisome) for treatment of cutaneous widespread candidosis in an infant with methylmalonic acidaemia. STOCKLER, S., LACKNER, H., GINTER, G., SCHWINGER, W., PLECKO, B., and MULLER, W., Eur. J. Pediatr., 1993, 152, (12), 981–983.
  • The cochlear blood flow: a comparison between the laser Doppler and the microsphere surface methods. OHI.SEN, A., HULTCRANTZ, E., LARSEN, H. C., and ANGELBORG, C., Acta otolaryngol., (Stockholm), 1994, 114, (1), 4–10.
  • Amphiphilic peptides enhance the efficiency of liposome-mediated DNA transfection. KAMATA, H., YAGISAWA, H., TAKAHASHI, S., and HIRATA, H., Nucleic Acids Res., 1994, 22, (3), 536–537.
  • Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (Am-Bisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. VAN ETTEN, E. W., VAN DEN HEUVEL DE GROOT, C., and BAKKER WOUDENBERG, I. A., J. Antimicrob. Chemother., 1993, 32, (5), 723–739.
  • Lyophilized liposome encapsulated hemoglobin: evaluation of hemodynamic, biochemical, and hematologic responses. RABINOVICI, R., RUDOLPH, A. S., VERNICK, J., and FEUERSTEIN, G., Crit. Care Med., 1994, 22, (3), 480–485.
  • Circulation persistence and biodistribution of lyophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid. RUDOLPH, A. S., CI.IFF, R. O., KLIPPER, R., GOINS, B., and PHILLIPS, W. T., Crit. Care Med., 1994, 22, (1), 142–150.
  • Long-term therapy of true precocious puberty in girls using Decapetyl-Depot, a superactive gonadoliberin agonist in depot microcapsulated form. SIPPELL, W. G., PARTSCH, C. J., HUMMELINK, R., and LORENZEN, F., Cesk. Pediatr., 1994, 49, (1), 13–18.
  • Comparison of antioxidant properties of nifedipine and illuminated nifedipine with nitroso spin traps in low density lipoproteins and phosphatidylcholine liposomes. ONDRIAS, K., MISIK, V., STASKO, A., GERGEL, D., and HROMADOVA, M., Biochim. Biophys. Acta, 1994, 1211, (1), 114–119.
  • Circulation persistence and biodistribution of lyophilized liposome-encapsulated hemoglobin: an oxygen-carrying resuscitative fluid. RUDOLPH, A. S., CLIFF, R. O., KLIPPER, R., GOINS, B., and PHILLIPS, W. T., Crit. Care Med., 1994, 22, (1), 142–150.
  • Long-term therapy of true precocious puberty in girls using Decapetyl-Depot, a superactive gonadoliberin agonist in depot microcapsulated form. SIPPELL, W. G., PARTSCH, C. J., HUMMELINK, R., and LORENZEN, F., Cesk. Pediatr., 1994, 49, (1), 13–18.
  • Comparison of antioxidant properties of nifedipine and illuminated nifedipine with nitroso spin traps in low density lipoproteins and phosphatidylcholine liposomes. ONDRIAS, K., MISIK, V., STASKO, A., GERGEL, D., and HROMADOVA, M., Biochim. Biophys. Acta, 1994, 1211, (1), 114–119.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.